Vasconcelos I, Perez Fernandez C M, Günzel S, Schoenegg W
Senologie Praxis am Kurfürstendamm, Berlin.
Radiology, Charité, Berlin.
Geburtshilfe Frauenheilkd. 2015 Feb;75(2):183-187. doi: 10.1055/s-0034-1383418.
PASH is a benign proliferation of stromal myofibroblasts that affects mostly premenopausal women and typically shows estrogen and progesterone receptor expression, allowing speculation regarding a hormonal cause. It usually presents as an incidental finding on a mammogram or as a palpable mass. We present a case of diffuse asymmetrical massive breast enlargement in a premenopausal woman with history of previous multiple PASH excisions for recurrent lesions, caused by multifocal tumorous PASH virtually replacing the breast parenchyma. Immunohistochemistry examination showed no hormone receptor expression. Despite its benign nature, such presentation of PASH is managed with bilateral mastectomy and immediate reconstruction with expanders for cosmetic and comfort reasons, while tumor excision or expectant management is deemed to lead to recurrence and progression. Although a hormonal origin is speculated based on hormone expression studies and typical patient profile, this case showed 0 % estrogen/progesterone expression in the final histology specimen.
富于细胞性纤维组织细胞瘤(PASH)是一种间质肌成纤维细胞的良性增生,主要影响绝经前女性,通常表现为雌激素和孕激素受体表达,这引发了关于激素病因的推测。它通常在乳房X线照片上偶然发现,或表现为可触及的肿块。我们报告一例绝经前女性出现弥漫性不对称性乳房巨大增大的病例,该女性既往因复发性病变多次进行PASH切除,此次是由多灶性肿瘤性PASH几乎取代乳腺实质所致。免疫组化检查显示无激素受体表达。尽管其本质为良性,但出于美容和舒适度的原因,这种PASH表现需行双侧乳房切除术并立即用扩张器进行重建,而肿瘤切除或观察等待治疗被认为会导致复发和进展。尽管基于激素表达研究和典型患者特征推测有激素起源,但该病例在最终组织学标本中显示雌激素/孕激素表达为0%。